Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Interesting that the BOD would consider selling this

Additional considerations were given to PTSC's expected improved traction in the justice and public safety markets, and the excellent results of the recent CDX technology evaluation which included the reassessment of CDX as a core driver for maximizing shareholder value

Yet less than 3 months after PR'ing this, Felcyn let one shareholder know that they were strongly considering it.

http://patriotscientific.com/index.php?option=com_content&task=view&id=245&Itemid=29

Share
New Message
Please login to post a reply